Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Okra and Reduced Hemoglobin A1c

Doses used in studies

mg/day: 3,000 (median 3,000, IQR 3,000–3,000) — 1 study

2 of 2 papers

Okra ameliorates hyperglycaemia in pre-diabetic and type 2 diabetic patients: A systematic review and meta-analysis of the clinical evidence.
- 2023-04-03
- Systematic Review · n = 331
- Frontiers in pharmacology 14
- - Kabelo Mokgalaboni
  - Sogolo Lucky Lebelo
  - Perpetua Modjadji
  - Saba Ghaffary
- PubMed: 37077817
- DOI: 10.3389/fphar.2023.1132650
2 Insights on
- Reduced Hemoglobin A1c
- High evidence
- Clinical
Glycated haemoglobin, however, did not differ significantly between the groups: MD = 0.01%; 95%CI (-0.51, 0.54, p = 0.96); I2 = 23%, p = 0.28.
Effect
Neutral
Effect size
Small
Significant
No
The cardiometabolic benefits of okra-based treatment in prediabetes and diabetes: a systematic review and meta-analysis of randomized controlled trials.
- 2024-12-12
- Systematic Review
- Frontiers in nutrition 11
- - Hossein Bahari
  - Mostafa Shahraki Jazinaki
  - Iman Rahnama
  - Ladan Aghakhani
  - Mohammad Reza Amini
  - Mahsa Malekahmadi
- PubMed: 39726865
- DOI: 10.3389/fnut.2024.1454286
4 Insights on
- Reduced Hemoglobin A1c
- High evidence
- Clinical
hemoglobin A1C (HbA1c) (WMD: -0.46 mg/dL; (95% CI: -0.79 to -0.13); p = 0.005)
Effect
Beneficial
Effect size
Moderate
Significant
Yes
Dose
≤3,000 mg/day